Results 171 to 180 of about 1,597,616 (181)
Some of the next articles are maybe not open access.

Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.

Acta anaesthesiologica Sinica, 1998
Rocuronium is a new nondepolarizing muscle relaxant. It features a rapid onset and lack of histamine release: It has an intermediate onset of action as vecuronium. The purpose of this study was to compare the neuromuscular action and condition of intubation after a bolus dose of rocuronium or vecuronium (2 x ED90).
P L, Lin   +5 more
openaire   +1 more source

Pharmacokinetics of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in humans.

Arzneimittel-Forschung, 1982
The pharmacokinetics of 2 beta, 16 beta-bis-(4'-dimethyl-1'-piperazino)-3 alpha, 17 beta-diacetoxy-5 alpha-androstane dibromide (pipecurium bromide, Arduan), a new non-depolarizing neuromuscular blocking agent, was studied in surgical patients. Plasma concentration-time curves of pipecurium bromide were evaluated by fitting the data to a bi-exponential
E, Tassonyi, G, Szabó, L, Vereczkey
openaire   +1 more source

DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND INTRAOCULAR PRESSURE IN VIVO

Anesthesiology, 1957
J B, DILLON   +3 more
openaire   +2 more sources

Determination of pipecurium bromide, a new non-depolarizing neuromuscular blocking agent, in human serum.

Arzneimittel-Forschung, 1981
A method for the determination of 2 beta, 16 beta-bis (4'dimethyl-1'-piperazino)-3a, 17 beta-diacetoxy-5 alpha-androstane is described. After deproteinization a pipecurium bromide Rose Bengal complex is formed and extracted with chloroform from a mildly basic medium.
G, Szabó, E, Tassonyi
openaire   +1 more source

Neuromuscular blocking agents and reversal agents

Anaesthesia and Intensive Care Medicine, 2021
Jennifer Hunter
exaly  

Safety aspects of non-depolarizing neuromuscular blocking agents with special reference to rocuronium bromide.

European journal of anaesthesiology. Supplement, 1994
The safety of neuromuscular relaxants can be assessed according to their cardiovascular and autonomic effects, their liability to release histamine, their tendency to cause anaphylactic/anaphylactoid reactions, their effect on cholinesterase, on intra-ocular and intracranial pressure, their tendency to cumulation and their reversibility.
openaire   +1 more source

The Interaction Between Suxamethonium and the Succeeding Non-Depolarizing Neuromuscular Blocking Agent

Survey of Anesthesiology, 1991
J. SWEN   +5 more
openaire   +1 more source

The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents.

Archives internationales de pharmacodynamie et de therapie, 1974
SCAF, AHJ   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy